As Vice-President, Preclinical Development, Geneviève’s oversight encompasses scientific, strategic, and managerial aspects of preclinical development, including early ADME-PK assessments, efficacy evaluations in animal disease models, as well as IND-enabling and chronic toxicology. Prior to her current role in the leadership team, Geneviève served as Director and Senior Director of Preclinical Development at Inversago Pharma.

Before joining Inversago, Geneviève was Manager of Research and Development at Confab Laboratories (Montreal) where she supervised a team of scientists and was involved in human and veterinary formulation development, spanning pre‑formulation processes through full-scale production batches for validation and regulatory submission. Geneviève holds a bachelor’s degree in pharmacy from Université Laval and a Ph.D. in drug delivery from the Faculty of Pharmacy of Université de Montréal.

• 

  Vice-President, Preclinical Development in Inversago Pharma

  Transformative therapies for the treatment of metabolic and fibrotic diseases